Baseline demographics and clinical characteristics of subjects enrolled in the phase 3 AURORA study of cenicriviroc for the treatment of liver fibrosis associated with non-alcoholic steatohepatitis

被引：0

作者：

Alkhouri, Naim ^{[1
]}

Wong, Vincent Wai-Sun ^{[2
]}

Jablkowski, Maciej ^{[3
]}

de Guevara, Alma Laura Ladron ^{[4
]}

Sheikh, Muhammad ^{[5
]}

Hodge, Alex ^{[6
]}

Elkhashab, Magdy ^{[7
]}

Strasser, Simone ^{[8
]}

Park, Grace S. ^{[9
]}

Landgren, Henrik ^{[10
]}

Tan, Bill ^{[11
]}

Massetto, Benedetta ^{[11
]}

Pecoraro, Maria Lucia ^{[11
]}

Seyedkazemi, Star ^{[11
]}

Martins, Eduardo Bruno ^{[11
]}

Fischer, Laurent ^{[11
]}

Abdelmalek, Manal ^{[12
]}

Tetri, Brent ^{[13
]}

Anstee, Quentin ^{[14
]}

机构：

[1] Univ Texas Hlth San Antonio, Texas Liver Inst, San Antonio, TX USA

[2] Chinese Univ Hong Kong, Hong Kong, Peoples R China

[3] Med Univ Lodz, Lodzkie, Poland

[4] Hosp Angeles Clin Londres, Mexico City, DF, Mexico

[5] Fresno Clin Res Ctr, Fresno, CA USA

[6] Monash Univ, Monash Med Ctr, Melbourne, Vic, Australia

[7] Toronto Liver Ctr, Toronto, ON, Canada

[8] Univ Sydney, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW, Australia

[9] Allergan PLC, Irvine, CA USA

[10] Allergan PLC, Marlow, Bucks, England

[11] Allergan PLC, San Francisco, CA USA

[12] Duke Univ, Durham, NC USA

[13] St Louis Univ, St Louis, MO 63103 USA

[14] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England

来源：

JOURNAL OF HEPATOLOGY | 2020年 / 73卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

FRI214

引用

页码：S508 / S508

页数：1

共 50 条

[41] RIP3-DEPENDENT NECROPTOSIS CONTROLS NON-ALCOHOLIC STEATOHEPATITIS INDUCED LIVER FIBROSIS VIA JNK
Gautheron, J.
Vucur, M.
Reisinger, F.
Roderburg, C.
Trautwein, C.
Tacke, F.
Heikenwalder, M.
Luedde, T.
JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S144 - S144
[42] BIOMARKERS OF LIVER FIBROSIS ARE SENSITIVE TO BOTH NAS AND FIBROSIS HISTOLOGICAL SCORE CHANGES IN NON-ALCOHOLIC STEATOHEPATITIS WITHIN THE CENTAUR STUDY
Leeming, Diana J.
Frederiksen, Peder
Fisker, Mette Juul
Daniels, Samuel Joseph
Seyedkazemi, Star
Sanyal, Arun J.
Anstee, Quentin M.
Schattenberg, Jorn M.
Karsdal, Morten Asser
Landgren, Henrik
Torstenson, Richard
HEPATOLOGY, 2020, 72 : 897A - 898A
[43] A Study on Association between Neutrophil to Lymphocyte Ratio and Steatohepatitis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
Jayachandra
Raksha, Sree K. N.
Desai, Rakshit R.
Chetan, V
Chandrashekar, Arjun P.
JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2021, 10 (25): : 1876 - 1882
[44] Randomised clinical trial: A phase 2 double-blind study of namodenoson in non-alcoholic fatty liver disease and steatohepatitis
Safadi, Rifaat
Braun, Marius
Francis, Adi
Milgrom, Yael
Massarwa, Muhammad
Hakimian, David
Hazou, Wadi
Issachar, Assaf
Harpaz, Zivit
Farbstein, Motti
Itzhak, Inbal
Lev-Cohain, Naama
Bareket-Samish, Avital
Silverman, Michael H.
Fishman, Pnina
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (11-12) : 1405 - 1415
[45] Performance of the Enhanced Liver Fibrosis (ELF) test in real world practice versus clinical trials of non-alcoholic steatohepatitis
Stepanova, Maria
Felix, Sean
Jeffers, Thomas
Younossi, Elena
Lam, Brian
Henry, Linda
Younossi, Zobair
JOURNAL OF HEPATOLOGY, 2022, 77 : S429 - S429
[46] Demographics and Baseline Characteristics of Children With Atopic Dermatitis Enrolled in a Randomized Phase 3 Study (TRuE-AD3)
Siri, Dareen
Lee, Lara Wine
Gold, Linda Stein
Armstrong, April
Brar, Kanwaljit
Holland, Kristen
Shepard, Julie
Devani, Alim
Sturm, Daniel
Angel, Brett
Li, Qian
Eichenfield, Lawrence
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB8 - AB8
[47] Anti-CD47 antibody treatment attenuates liver inflammation and fibrosis in experimental non-alcoholic steatohepatitis models
Gwag, Taesik
Ma, Eric
Zhou, Changcheng
Wang, Shuxia
LIVER INTERNATIONAL, 2022, 42 (04) : 829 - 841
[48] Safety and efficacy of resmetirom in the treatment of patients with non-alcoholic steatohepatitis and liver fibrosis: a systematic review and meta-analysis
Raja, Adarsh
Sagar, Raja Subhash
Saeed, Sadia
ul Haq, Amna Zia
Khan, Owais
Bhimani, Parshant Dileep
Raja, Sandesh
Deepak, Fnu
Ahmed, Muhammad
Shafique, Muhammad Ashir
Mustafa, Muhammad Saqlain
Asghar, Muhammad Sohaib
Sharma, Varsha
ANNALS OF MEDICINE AND SURGERY, 2024, 86 (07): : 4130 - 4138
[49] A metagenomic study identifies a Prevotella copri enriched microbial profile associated with non-alcoholic steatohepatitis in subjects with obesity
Moran-Ramos, Sofia
Cerqueda-Garcia, Daniel
Lopez-Contreras, Blanca
Larrieta-Carrasco, Elena
Villamil-Ramirez, Hugo
Molina-Cruz, Selene
Torres, Nimbe
Sanchez-Tapia, Monica
Hernandez-Pando, Rogelio
Aguilar-Salinas, Carlos
Villarreal-Molina, Teresa
Canizales-Quinteros, Samuel
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 (05) : 791 - 799
[50] The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment
Yu, Lili
Hong, Wei
Lu, Shen
Li, Yanrong
Guan, Yaya
Weng, Xiaogang
Feng, Zhiwei
FRONTIERS IN PHARMACOLOGY, 2022, 13

← 1 2 3 4 5 →